Monokine production following in vitro stimulation of the THP-1 human monocytic cell line with pertussis vaccine components.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 9475357)

Published in J Clin Immunol on January 01, 1998

Authors

J Blood-Siegfried1, E Crabb Breen, S Takeshita, O Martinez-Maza, D Vredevoe

Author Affiliations

1: UCLA School of Nursing, UCLA School of Medicine, Los Angeles, California 90095, USA.

Articles cited by this

The pathophysiology of tumor necrosis factors. Annu Rev Immunol (1992) 8.38

Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58

Interleukin-6: an overview. Annu Rev Immunol (1990) 7.48

Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem (1990) 5.36

Infection with HIV is associated with elevated IL-6 levels and production. J Immunol (1990) 3.89

Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun (1994) 2.92

The concept of pertussis as a toxin-mediated disease. Pediatr Infect Dis (1984) 2.45

Constitutive sensory transduction mutations in the Bordetella pertussis bvgS gene. J Bacteriol (1992) 1.91

Leukocytosis-promoting factor of Bordetella pertussis. II. Biological properties. Infect Immun (1973) 1.77

Autogenous regulation of the Bordetella pertussis bvgABC operon. Proc Natl Acad Sci U S A (1990) 1.72

Pertussis toxin inhibition of B cell and macrophage responses to bacterial lipopolysaccharide. Science (1986) 1.61

Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol (1990) 1.55

Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying. Pediatrics (1993) 1.49

Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res (1990) 1.42

Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy. Pediatrics (1990) 1.18

IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma. J Immunol (1991) 1.12

Workshop on neurologic complications of pertussis and pertussis vaccination. Neuropediatrics (1990) 1.10

Dual effects of pertussis toxin on lymphoid cells in culture. Cell Immunol (1986) 0.96

Time course of various inflammatory mediators during recurrent endotoxemia. Biochem Pharmacol (1992) 0.96

Identification of two bvg-repressed surface proteins of Bordetella pertussis. Infect Immun (1995) 0.95

Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain. Pediatr Infect Dis J (1989) 0.94

Cytokine-associated tissue injury and lethality in mice: a comparative study. Clin Immunol Immunopathol (1991) 0.90

Polymyxin B inactivation of lipopolysaccharide in vaccines of Gram-negative bacteria. Infect Immun (1981) 0.88

The current status of pertussis vaccine: an overview. Adv Appl Microbiol (1976) 0.88

Effect of hyperreactivity to endotoxin on the toxicity of pertussis vaccine and pertussis toxin in mice. Vaccine (1989) 0.86

Role of endotoxin in alterations of hepatic drug metabolism by diphtheria and tetanus toxoids and pertussis vaccine adsorbed. Infect Immun (1992) 0.85

Evaluation of the mouse model for study of encephalopathy in pertussis vaccine recipients. Infect Immun (1989) 0.82

Lipopolysaccharide induces interleukin-6 release from rat peritoneal macrophages in vitro: evidence for a novel mechanism. Circ Shock (1993) 0.78

Metabolic and hematologic effects and immune complex formation related to pertussis immunization. Pediatr Res (1990) 0.78

Modulation of hepatic mRNA levels after administration of lipopolysaccharide and diphtheria and tetanus toxoids and pertussis vaccine adsorbed (DTP vaccine) to mice. Hepatology (1994) 0.78

Pertussis toxin-induced alterations of murine hepatic drug metabolism following administration of diphtheria and tetanus toxoids and pertussis vaccine adsorbed. Infect Immun (1993) 0.77

Pertussis toxin-induced mitogenesis in human T lymphocytes. Immunopharmacology (1991) 0.77

Production and release of tumor necrosis factor alfa, interleukin-1B and interleukin-6 by human mononuclear leukocytes stimulated with pertussis toxin. New Microbiol (1993) 0.77

Depression of liver metabolism and induction of cytokine release by diphtheria and tetanus toxoids and pertussis vaccines: role of Bordetella pertussis cells in toxicity. Infect Immun (1994) 0.77

Primary immunization series for infants: comparison of two-component acellular and standard whole-cell pertussis vaccines combined with diphtheria-tetanus toxoids. South Med J (1993) 0.77

The in vitro invasive behavior of human myelomonocytic cell lines is modulated by HuIFN-gamma and pertussis toxin. J Biol Response Mod (1989) 0.76

Articles by these authors

(truncated to the top 100)

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest (2000) 5.78

Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res (1999) 4.68

Infection with HIV is associated with elevated IL-6 levels and production. J Immunol (1990) 3.89

Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem (2000) 2.80

Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation (1996) 2.79

Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol (2001) 2.49

A new murine model of accelerated senescence. Mech Ageing Dev (1981) 2.40

The multicenter AIDS Cohort Study, 1983 to …. Public Health (2011) 1.93

Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation (1995) 1.92

Is the E receptor on human T lymphocytes a "negative signal receptor"? J Immunol (1982) 1.83

Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. J Biol Chem (1994) 1.70

Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation (1995) 1.51

Brain metastasis of Merkel cell carcinoma. Case report and review of the literature. Neurosurg Rev (1999) 1.51

Risk factors for non-Hodgkin's lymphomas in acquired immunodeficiency syndrome (AIDS) Am J Epidemiol (1996) 1.50

Efficacy of a new hemostatic device, Adapty , after transradial coronary angiography and intervention. J Invasive Cardiol (2000) 1.38

Grading score system: a method for evaluation of the degree of senescence in senescence accelerated mouse (SAM). Mech Ageing Dev (1984) 1.36

Simulation of intracellular Ca2+ oscillation in a sympathetic neurone. J Theor Biol (1981) 1.30

Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity. J Immunol (1985) 1.28

Maternal-fetal incompatibility. I. Incidence of HL-A antibodies and possible association with congenital anomalies. Transplantation (1970) 1.28

Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits. Atherosclerosis (2001) 1.28

Monoclonal antibodies against HLA-DR antigens replace T helper cells in activation of B lymphocytes. Proc Natl Acad Sci U S A (1983) 1.28

Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension (1999) 1.23

Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol (1994) 1.22

Anatomic variations of the radial artery in patients undergoing transradial coronary intervention. Catheter Cardiovasc Interv (2000) 1.21

Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation (1999) 1.20

Spontaneous production of interferon-gamma in adult and newborn humans. J Immunol (1984) 1.20

Targeted disruption of cadherin-11 leads to a reduction in bone density in calvaria and long bone metaphyses. J Bone Miner Res (2001) 1.16

Systemic senile amyloid in senescence-accelerated mice. A unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab Invest (1983) 1.14

The transition of cadherin expression in osteoblast differentiation from mesenchymal cells: consistent expression of cadherin-11 in osteoblast lineage. J Bone Miner Res (2001) 1.13

Spontaneous age-associated amyloidosis in senescence-accelerated mouse (SAM). Mech Ageing Dev (1982) 1.13

The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk. Cancer Causes Control (2007) 1.09

Structural features in heparin that interact with VEGF165 and modulate its biological activity. Glycobiology (1999) 1.09

Cataract and other ophthalmic lesions in senescence accelerated mouse (SAM). Morphology and incidence of senescence associated ophthalmic changes in mice. Exp Eye Res (1984) 1.08

Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg (1995) 1.08

Isolation and characterization of senile amyloid--related antigenic substance (SASSAM) from mouse serum. Apo SASSAM is a low molecular weight apoprotein of high density lipoprotein. J Exp Med (1983) 1.07

Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis (2001) 1.06

Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury. J Leukoc Biol (2001) 1.06

Purification and characterization of a senile amyloid-related antigenic substance (apoSASSAM) from mouse serum. apoSASSAM is an apoA-II apolipoprotein of mouse high density lipoproteins. J Biol Chem (1986) 1.02

Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int J Cancer (1992) 1.02

Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection. J Infect Dis (1998) 1.01

Nosocomial meningitis due to Campylobacter fetus subsp. fetus in a neonatal intensive care unit. Eur J Pediatr (1988) 1.00

Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells. Hepatology (1999) 1.00

Functional association of CD9 with the Fc gamma receptors in macrophages. J Immunol (2001) 1.00

Anomalous cadherin expression in osteosarcoma. Possible relationships to metastasis and morphogenesis. Am J Pathol (1999) 1.00

Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival. Am J Surg Pathol (1993) 0.99

Tetrahedral magnetic order and the metal-insulator transition in the pyrochlore lattice of Cd2Os2O7. Phys Rev Lett (2012) 0.99

Production of human immune interferon (Hu IFN-gamma) studied at the single cell level. Origin, evidence for spontaneous secretion and effect of cyclosporin A. Eur J Immunol (1983) 0.99

Circulating endothelial cells in Kawasaki disease. Clin Exp Immunol (2003) 0.99

Relationship of plasma HIV-RNA levels and levels of TNF-alpha and immune activation products in HIV infection. Clin Immunol Immunopathol (1997) 0.99

Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest (1992) 0.99

Various factors associated with the manifestation of influenza-like illness. Int J Epidemiol (1992) 0.98

Isolation of mouse and human cDNA clones encoding a protein expressed specifically in osteoblasts and brain tissues. Biochem Biophys Res Commun (1990) 0.97

Secretion of gamma-interferon at the cellular level. Induction by Epstein-Barr virus. Scand J Immunol (1984) 0.97

Regulation of HIV-1 infection in astrocytes: expression of Nef, TNF-alpha and IL-6 is enhanced in coculture of astrocytes with macrophages. J Neurovirol (1996) 0.97

Induction of IL-6 and IL-10 production by recombinant HIV-1 envelope glycoprotein 41 (gp41) in the THP-1 human monocytic cell line. Cell Immunol (1995) 0.97

Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum Gene Ther (1996) 0.97

Structure of extrachromosomal circular DNAs excised from T-cell antigen receptor alpha and delta-chain loci. J Mol Biol (1988) 0.97

Participation of a dominant cytotoxic T cell population defined by a monoclonal antibody in syngeneic anti-tumor responses. Eur J Immunol (1990) 0.96

Excision products of immunoglobulin gene rearrangements. Immunol Lett (1989) 0.96

Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species. Leukemia (2008) 0.96

A VH clonal deficit in human immunodeficiency virus-positive individuals reflects a B-cell maturational arrest. Blood (1991) 0.95

Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer (1992) 0.95

Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-alpha. Am J Obstet Gynecol (1992) 0.94

Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo. Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation (1994) 0.94

Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev (1999) 0.94

A regulatory factor, Fil1p, involved in derepression of the isocitrate lyase gene in Saccharomyces cerevisiae--a possible mitochondrial protein necessary for protein synthesis in mitochondria. Eur J Biochem (1998) 0.93

Expression and function of the splice variant of the human cadherin-11 gene in subordination to intact cadherin-11. J Bone Miner Res (1999) 0.93

Improved vector, pHSG664, for direct streptomycin-resistance selection: cDNA cloning with G:C-tailing procedure and subcloning of double-digest DNA fragments. Gene (1986) 0.93

Conserved V(D)J junctional sequence of cross-reactive cytotoxic T cell receptor idiotype and the effect of a single amino acid substitution. Eur J Immunol (1991) 0.93

Efficacy of transradial primary stenting in patients with acute myocardial infarction. Am J Cardiol (1999) 0.92

Cornea-responsive medullary dorsal horn neurons: modulation by local opioids and projections to thalamus and brain stem. J Neurophysiol (2000) 0.92

Delayed apoptosis of circulating neutrophils in Kawasaki disease. Clin Exp Immunol (2001) 0.92

Blood transfusion, alcohol consumption, and cigarette smoking in causation of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Jpn J Cancer Res (1988) 0.92

Role of epidermal growth factor and its receptor in mechanical stress-induced differentiation of human periodontal ligament cells in vitro. Arch Oral Biol (1998) 0.91

Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats. Diabetes Obes Metab (2007) 0.90

Clinical and radiological variability of influenza-related encephalopathy or encephalitis. Acta Paediatr Jpn (1998) 0.89

Response properties of TMJ units in superficial laminae at the spinomedullary junction of female rats vary over the estrous cycle. J Neurophysiol (2003) 0.89

Drug resistance and R plasmids in Vibrio anguillarum isolated in cultured ayu (Plecoglossus altivelis). Microbiol Immunol (1984) 0.89

Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum Gene Ther (1993) 0.88

Functional recovery in hemiplegic cerebral palsy: ipsilateral electromyographic responses to focal transcranial magnetic stimulation. Brain Dev (1999) 0.87

Cloning, expression profile, and genomic organization of the mouse STAP/A170 gene. Genomics (1999) 0.87

DNA vaccines: capacity to induce auto-immunity and tolerance. Dev Biol (Basel) (2000) 0.87

The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma. Cancer (1993) 0.87

Age-related changes of serum apoprotein SASSAM, apoprotein A-I and low-density lipoprotein levels in senescence accelerated mouse (SAM). Mech Ageing Dev (1984) 0.87

Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation (1995) 0.87

Uterine metastasis from hepatocellular carcinoma: A case report. Int J Gynecol Cancer (2006) 0.87

[Fundamental and clinical studies on PLV2 (Octapressin)]. Masui (1966) 0.86

Survival of breast-cancer patients and body size indicators. Int J Cancer (1990) 0.86

Cloning and characterization of OSF-3, a new member of the MER5 family, expressed in mouse osteoblastic cells. J Biochem (1994) 0.86

Detection of interleukin-6 in human follicular fluid. Fertil Steril (1992) 0.85

Diet and prognosis of breast cancer. Nutr Cancer (1992) 0.85

Chronic food restriction modulates the advance of senescence in the senescence accelerated mouse (SAM). J Nutr (1985) 0.85

Interleukin 6 is essential for antibody secretion by human in vivo antigen-induced lymphoblastoid B cells. Cell Immunol (1990) 0.85

Anthropometric indicators of breast cancer risk in Japanese women in Fukuoka. Jpn J Cancer Res (1990) 0.84

Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation (1997) 0.84

Isolated congenital left ventricular diverticulum with perinatal dysrhythmia: a case report and review of the literature. Pediatr Cardiol (2000) 0.84

Inhibition of IL-12 synthesis of peripheral blood mononuclear cells (PBMC) stimulated with a bacterial superantigen by pooled human immunoglobulin: implications for its effect on Kawasaki disease (KD). Clin Exp Immunol (1998) 0.84

Liposome-mediated gene transfer into human vascular smooth muscle cells. Circulation (1994) 0.84

Regulation of the expression of Fc gamma receptor on circulating neutrophils and monocytes in Kawasaki disease. Clin Exp Immunol (1999) 0.84

Vascular endothelial growth factor expression is not regulated by estradiol or medroxyprogesterone acetate in endometrial carcinoma. Gynecol Oncol (1996) 0.83